-transparent.png){kind=logo}
Seven rat rhabdomyosarcoma cell lines, 9-4/0, F6, F8, F13, F21, R3 and R9, were cytogenetically investigated. They differed in their metastatic, tumorigenic and growth potential, and in resistance to chlorozotocin (CZT = 2,3-[2-chloroethyl]-3-nitrosoureido-beta-D-glucopyranose). No strict correlation between phenotypic features and chromosomal aberrations existed; however, rearrangements specific for each line were found. Twenty-one chromosome markers, present in a minimum of 20% of cells of a line, were observed. Chromosomes 3, 7, 10, 11 and 13, were those most often involved in marker formation. Two CZT-resistant lines, R3 and R9, showed no common aberration, but R9 which was most resistant, was shown to have a homogeneously staining region, which is usually thought to be the site of gene amplification.
O Haus, and
C Pauwels, and
M F Poupon, and
R Berger
January 1979,
Journal of supramolecular structure,
O Haus, and
C Pauwels, and
M F Poupon, and
R Berger
January 2011,
Asian Pacific journal of cancer prevention : APJCP,
O Haus, and
C Pauwels, and
M F Poupon, and
R Berger
March 2010,
Cytokine,
O Haus, and
C Pauwels, and
M F Poupon, and
R Berger
July 1965,
American journal of veterinary research,
O Haus, and
C Pauwels, and
M F Poupon, and
R Berger
January 1989,
International journal of cancer,
O Haus, and
C Pauwels, and
M F Poupon, and
R Berger
May 2020,
Scientific reports,
O Haus, and
C Pauwels, and
M F Poupon, and
R Berger
April 1998,
Clinical & experimental metastasis,
O Haus, and
C Pauwels, and
M F Poupon, and
R Berger
January 2002,
Oncology reports,
O Haus, and
C Pauwels, and
M F Poupon, and
R Berger
February 2002,
Cancer chemotherapy and pharmacology,
O Haus, and
C Pauwels, and
M F Poupon, and
R Berger
January 2019,
Theranostics,
